Heron Therapeutics Inc (HRTX)

R&D Expense Growth

13.29%

Quarterly · Period ending:

HRTX logo

HRTX R&D Expense Growth

Latest reported13.29%
HRTX Quarterly R&D Growth (QoQ) (0.00% → 13.29%)
High-resolution chart · PNG

HRTX r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Heron Therapeutics Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
13.2914%
-36.3321%
7.9539%
18.2686%
28.7407%
-28.2882%
-28.8242%
0.7446%
-3.8194%
-57.9178%
-19.2359%
2.6344%
49.502%
-20.0868%
-56.7156%
-11.4067%
-31.4618%
45.6869%
0.9862%
-18.8403%
-7.5638%
-14.2555%
-9.6153%
11.7671%
19.2714%
-23.5785%
39.0947%
-16.2148%
-3.6%
7.7235%
31.1298%
0.8687%
-23.7658%
-17.1619%
65.57%
0.8637%
-14.3392%
13.1469%
-2.437%
10.8334%
69.5625%
-1.0515%
14.1984%
-11.9567%
11.521%
2.1768%
-3.6386%
2.1072%
22.5639%
22.7168%
54.3115%
-40.9743%
55.508%
34.8198%
38.5273%
18.2263%
-7.8702%
16.6025%
-2.5265%
128.4711%
12.3576%
-24.0346%
-2.5308%
-18.4656%
-18.9189%
64.1549%
0.141%
-51.238%
41.8537%
-25.7246%
-45.5514%
-8.4688%
-9.8046%
1.9934%
31.012%
22.11%
-24.5438%
4.0476%
53.7203%
-19.139%
11.156%
12.1202%
34.1717%
-25.0812%
68.9352%
-35.8451%
12.609%
-13.1842%
-4.2834%
33.7594%
22.384%
-20.5996%
6.04%
51.2363%
-22.3052%
0.1068%
25.0501%
-38.6224%
22.7479%
28.6917%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.